MAZE Sale Disclosure
Dandekar Atul · SEC Form 4 · Filed Oct 30, 2026
Sale
Calculated transaction value
$240.53K
Dandekar Atul Csbo
MAZE
Maze Therapeutics
MAZE
Transaction date
Oct 29, 2026
Public filing date
Oct 30, 2026
Filing lag
Filed 1 day later
MAZE daily price context
Close on/before transaction
$31.93
Oct 29, 2026
First close after public filing
$30.37
Nov 2, 2026
Return after filing · so far
+12.58%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,500 shares @ $32.07
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002050167-26-000032
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$318.68K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Maze Therapeutics, Inc. MAZE | Exercise | Oct 29, 2026 | $69.22K |
| Maze Therapeutics, Inc. MAZE | Exercise | Oct 29, 2026 | $0 |
| Maze Therapeutics, Inc. MAZE | Exercise | Oct 29, 2026 | $8.93K |
| Maze Therapeutics, Inc. MAZE Current | Sale | Oct 29, 2026 | $240.53K |
| Maze Therapeutics, Inc. MAZE | Exercise | Oct 29, 2026 | $0 |